SANDOZ A/S

CVR: 27744532

Growing 8% p.a.Medium companyWell-established (21 yrs)Breakeven

Secondary names: DURASCAN A/S, DURASCAN MEDICAL PRODUCTS A/S, HEXAL SCANDINAVIA A/S

Previous names: DURASCAN MEDICAL PRODUCTS A/S

Active
Own this company?

SANDOZ A/S demonstrates a solid financial health with a consistent upward trajectory in revenue, reaching 2.52 billion DKK in 2024, up from 2.29 billion DKK in 2023. However, profit has decreased from 68.5 million DKK in 2023 to 48 million DKK in 2024, indicating potential margin pressures. The company's equity has improved significantly, standing at 577.6 million DKK, reflecting a strong capital position within the pharmaceutical wholesale industry. Despite the recent dip in profitability, SANDOZ A/S maintains a robust revenue growth trend, positioning itself favorably among competitors.

AI-generated summary

Overview

Company type
A/S
Aktieselskab
Address
Edvard Thomsens Vej 14 1., 2300 København S
Founded
17.5.2004

Details

Employees
136 employees
118 FTE
(2018)
Capital
12.000.000 kr.

Purpose

Selskabets formål er at drive handel, industri og finansiering samt anden dermed beslægtet virksomhed, herunder at drive virksomhed gennem datterselskaber.

Financials

Financial trend

Upgrade to Pro to see financial trends and development over time

See trends with Pro
YearRevenueProfit/LossTotal AssetsEquityEmployeesReport
20242.5 mia.48 mio.1.5 mia.577.6 mio.106

History

Ownership

SANDOZ A/S
CVR: 27744532

Management

Directors

Board

Lawrence Edward Mead(BESTYRELSESMEDLEM)
Nete Brændgaard(BESTYRELSESMEDLEM)

Production units (9)

SANDOZ A/S
P-no: 1003151627
Edvard Thomsens Vej 14 1., 2300, København S
Engroshandel med medicinalvarer og sygeplejeartikler
136 employees

Similar companies

Companies in the same industry and area

Is this your company?

Claim this page to add your logo and social links. Free to get started.